WASIF SHIRAZI, M.D.
Hematology & Oncology Physician · TINLEY PARK, IL
Individual Active NPI 1558336149
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 927 | 327,657 | $23,807,254 | $6,642,893 | $5,280,659 |
| 2023 | 869 | 357,885 | $21,292,828 | $5,409,423 | $4,294,532 |
| 2022 | 855 | 287,812 | $17,510,000 | $4,580,903 | $3,639,422 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 57,860 | $3 | $2 |
| J1439 | Injection, ferric carboxymaltose, 1 mg | 36,750 | $1 | $1 |
| J9025 | Injection, azacitidine, 1 mg | 18,050 | $0 | $0 |
| J9263 | Injection, oxaliplatin, 0.5 mg | 16,600 | $0 | $0 |
| J9299 | Injection, nivolumab, 1 mg | 14,600 | $31 | $25 |
| J9271 | Injection, pembrolizumab, 1 mg | 13,800 | $56 | $45 |
| J9119 | Injection, cemiplimab-rwlc, 1 mg | 10,500 | $27 | $22 |
| J9144 | Injection, daratumumab, 10 mg and hyaluronidase-fihj | 9,720 | $49 | $39 |
| J1453 | Injection, fosaprepitant, 1 mg | 9,150 | $0 | $0 |
| J0897 | Injection, denosumab, 1 mg | 6,480 | $26 | $21 |
| J1437 | Injection, ferric derisomaltose, 10 mg | 5,200 | $20 | $16 |
| J1449 | Injection, eflapegrastim-xnst, 0.1 mg | 4,620 | $26 | $20 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Hematology & Oncology Physician | 207RH0003X | ✓ | 036099502 | IL |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Hematology & Oncology Physician providers in Illinois
- NPI 1083704449
- NPI 1609868819
- NPI 1588607923
- NPI 1598757718
- NPI 1427255447
- NPI 1740256783
- NPI 1427218452
- NPI 1992797047
See all Hematology & Oncology Physician providers in Illinois →
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.